Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
Integration of Immunotherapy Across
by pamella-moone
the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...
Slides last updated:
by stefany-barnette
October 2013 . Ferlay . J, Shin HR, Bray F, Forma...
Second line
by alida-meadow
treatments. in WT . pts. : . which. . opportuni...
Integration of Immunotherapy Across
by karlyn-bohler
the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...
Slides last updated:
by calandra-battersby
October 2013. There are two main types of lung . ...
Detection of Mutations in EGFR in Circulating Lung-Cancer C
by sherrill-nordquist
Colin Reisterer and Nick Swenson. S. . Maheswaran...
Lung malignancy
by tawny-fly
Dr. Rachel Cary, FY1 Warwick Hospital. Learning ...
Targeting KRAS and down streaming
by alexa-scheidler
pathways. Federico Cappuzzo. Istituto Toscano Tum...
Terapia
by min-jolicoeur
targeted. : . limiti e successi nelle metastasi ...
Checkpoint inhibitors for
by paisley
NSCLC. An update. Solange Peters, MD-PhD. Oncology...
Lung Tumors
by lorenzo155
4/1/24. Michael Forte, MD. Outline . Lung Cancer ...
INTRODUCTION RESULTS
by arjun383
Mason Alford, MSc. a. , . Candace J. Grisham, MS. ...
Phase II studies of Nivolumab
by brianna
in patients with Advanced . Squamous. (SQ) or Non...
The formula Blueprint Medicines (BPMC)
by erica
The sum of Blueprint’s pieces exceeds current va...
Striving for Consensus on the
by samantha
Optimal Management of Metastatic . Non-Small Cell ...
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
by finley
Università . di Napoli “Federico II”. Innovat...
Second line treatments in WT
by deena
pts. : . which. . opportunities. with . biologic...
Istituto Toscano Tumori –Livorno, Italy
by payton
Federico . Cappuzzo. Istituto Toscano Tumori. Ospe...
New developments in oncological treatment for Stage 3 NSCLC
by summer
Lung SSG 22. nd. May 2018. Gareth Ayre. Rationale...
CLINICAL EXPERIENCE OF NSCLC in RSDM
by sophia
Ana Rima. PENDAHULUAN. 2. Kanker Paru. P. enyebab ...
FIRST-LINE EGFRm+ NSCLC PATIENT CASE STUDY
by pamela
Case study 9. Provided by . Dr Qamar Ghafoor, Clin...
Updates in the systemic treatment for lung
by madeline
cancer: Immunotherapy. Oscar Arrieta MD. Thoracic....
Small cell lung cancer (SCLC):
by faith
an . introduction. Last updated: . July . 2020. In...
The Winship Cancer Institute of Emory University
by jalin
July 22, 2023. Adjuvant immunotherapy for resectab...
ALK in lung cancer: Past, present, and future
by belinda
Gene Mutations in Lung . Adenocarcinomas. 17 years...
AdjuvantTherapyforStageIandIINonSmallCellLungCancerEvanCNaylorPatie
by susan2
DisclosureStatement:Theauthorhasnothingtodisclose....
NonSmallCellLungCancerVersion32022DavidSEttingerMDDouglasEWoodM
by cecilia
NCCNCATEGORIESOFEVIDENCEANDCONSENSUSCategory1:Base...
cell lung cancer NSCLCESMO Clinical Practice Guidelines for diagnosi
by adia
RecommendationLoE, GoRScreening with LDCT (low-dos...
Jchem applications in Medchem
by StarsAndStripes
Prediction. . and. . Data Sorting. Zhengtao. Li...
ALL, Acute lymphoblastic leukemia;
by HappyHippo
BCMA, B-cell maturation antigen; DLBCL, diffuse la...
mRNA anticancer Vaccines
by byrne
breakthrough. . approach. in . cancer. . treatm...
iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung
by berey
Interview with Shirish M . Gadgeel. , MD . January...
Mechanisms of ALK Resistance & Implications for Treatment
by evans
Robert C. Doebele, MD, PhD. Associate Professor, ....
Targeting KRAS G12C in Solid Tumors
by morton
: . A . New Anticancer Approach . Marwan Fakih, ...
Load More...